Jane Street’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
310,400
+283,400
+1,050% +$8.63M ﹤0.01% 2650
2026
Q1
$671K Sell
27,000
-112,200
-81% -$2.9M ﹤0.01% 7357
2025
Q4
$3.54M Buy
139,200
+59,600
+75% +$1.33M ﹤0.01% 3774
2025
Q3
$1.28M Buy
79,600
+22,000
+38% +$356K ﹤0.01% 5793
2025
Q2
$922K Sell
57,600
-106,200
-65% -$1.61M ﹤0.01% 5769
2025
Q1
$2.8M Buy
163,800
+95,500
+140% +$2M ﹤0.01% 3819
2024
Q4
$1.69M Sell
68,300
-200
-0.3% -$5.67K ﹤0.01% 4421
2024
Q3
$1.95M Buy
68,500
+8,900
+15% +$262K ﹤0.01% 4525
2024
Q2
$1.57M Sell
59,600
-22,500
-27% -$640K ﹤0.01% 4921
2024
Q1
$2.65M Buy
82,100
+20,400
+33% +$744K ﹤0.01% 3615
2023
Q4
$2.6M Sell
61,700
-182,700
-75% -$6.72M ﹤0.01% 3864
2023
Q3
$9.38M Buy
+244,400
New +$5.52M ﹤0.01% 1851
2023
Q1
Sell
-13,100
Closed -$233K 9441
2022
Q4
$233K Buy
+13,100
New +$165K ﹤0.01% 7433
2022
Q1
Sell
-83,300
Closed -$710K 10644
2021
Q4
$710K Sell
83,300
-460,400
-85% -$3.8M ﹤0.01% 6602
2021
Q3
$4.72M Sell
543,700
-138,000
-20% -$1.24M ﹤0.01% 2831
2021
Q2
$7.21M Buy
+681,700
New +$9.52M ﹤0.01% 2111

Other funds holding IMVT

Jane Street's IMVT Position: Q2 2026 in Review

Jane Street sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 84,312 shares — an estimated $2.57M sold.

Jane Street first reported a position in IMVT in Q1 2020 and held it in 21 quarters. The position peaked at $25.9M in Q4 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jane Street reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 84,312 Immunovant shares in Q2 2026, an estimated $2.57M.
  • Jane Street first reported a position in Immunovant in Q1 2020 and held it in 21 quarters.
  • Jane Street's Immunovant position peaked at $25.9M in Q4 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.